Allschwil, Switzerland

Christoph Sager

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christoph Sager: Innovator in Pharmaceutical Chemistry

Introduction

Christoph Sager is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as Galectin-3 inhibitors. With a total of five patents to his name, Sager's work is recognized for its potential impact on therapeutic applications.

Latest Patents

Sager's latest patents include innovative compounds such as Alpha-D-galactopyranoside derivatives. This invention relates to compounds of Formula (I), which include various structural components and their preparation. These compounds are particularly noteworthy for their use as pharmaceuticals and their potential as Galectin-3 inhibitors. Another significant patent is for Spiro derivatives of Alpha-D-galactopyranosides, which also focuses on compounds of Formula (I) and their pharmaceutical applications.

Career Highlights

Christoph Sager is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new therapeutic options that could benefit patients with various health conditions.

Collaborations

Sager collaborates with esteemed colleagues such as Martin Bolli and John Gatfield, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christoph Sager's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…